A U.S. appeals court on Friday revived more than 500 lawsuits alleging that Merck & Co failed to warn that its osteoporosis ...

(Reuters) - A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Merck (MRK) reachead $117.17 at the closing of the latest trading day, reflecting a -0.05% change compared to its last close.

The Pan American Health Organisation has launched a partnership with Merck & Company to improve health care and maternal health outcomes for women ...

Pharma giant Merck applies the technology to streamline IT operations. Such examples speak of the versatility of the software. Furthermore, these successes have made the Now platform a favorite among ...

The US stock markets opened lower on Friday, September 20, as investors held back after a jump in the previous session, which ...

Merck (NYSE: MRK), known as MSD outside of the United States ... which occurs in many cardiovascular diseases that can lead to heart dysfunction and failure. The Company plans on releasing new data ...

Shares of Bicara Therapeutics—a biopharmaceutical company backed by Indian billionaire Kiran Mazumdar-Shaw—surged about 42% ...

After penning a letter to the world’s cardinals asking them to focus on financial reform, urging spending cuts and ...